Trodelvy showed fewer severe side effects, such as neutropenia and diarrhea, compared to chemotherapy in untreated TNBC ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the ...

Vitamin B6 deficiency symptoms include mood changes, mouth sores, skin lesions, nerve damage, loss of muscle control, seizures, and more.

T-DXd regimens improved pathologic complete response and safety profiles compared to ddAC-THP in high-risk, HER2-positive early breast cancer. Patient-reported outcomes showed better physical ...

Chemotherapy-induced peripheral neuropathy (CIPN) affects cancer survivors, impacting quality of life. Podiatry care can help manage symptoms and complications.

J&J has received the US FDA approval for Rybrevant Faspro, a SC administered therapy to treat patients with EGFR-mutated ...

Patients with HER2-positive, hormone receptor (HR)-positive metastatic breast cancer can be safely treated without chemotherapy.

Downstairs on a Wednesday afternoon, you'll find the entire basement of Peak Pickleball filled with players, some more ...

Overall survival data showed a 50% reduction in the risk of death with the regimen compared with surgery alone.

MediciNova (MNOV) completed patient enrollment in the Phase 2 clinical trial, the OXTOX study – Oxaliplatin Neurotoxicity study in patients with metastatic colorectal cancer -. This study is ...

This week, Bobbi Conner talks with Dr. Katie Schmitt about oncology physical therapy. Dr. Schmitt is a Doctor of Physical Therapy and a clinical specialist in oncologic physical therapy and certified ...